- Home
- KZIA vs OTRK Comparison
KZIA vs OTRK Comparison
Compare KZIA & OTRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- OTRK
- Stock Information
- Founded
- KZIA 1994
- OTRK 2003
- Country
- KZIA Australia
- OTRK United States
- Employees
- KZIA N/A
- OTRK N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- OTRK Misc Health and Biotechnology Services
- Sector
- KZIA Health Care
- OTRK Health Care
- Exchange
- KZIA Nasdaq
- OTRK Nasdaq
- Market Cap
- KZIA 5.1M
- OTRK 2.1M
- IPO Year
- KZIA 1999
- OTRK N/A
- Fundamental
- Price
- KZIA $10.45
- OTRK $0.44
- Analyst Decision
- KZIA Strong Buy
- OTRK Strong Buy
- Analyst Count
- KZIA 2
- OTRK 1
- Target Price
- KZIA $14.00
- OTRK $3.00
- AVG Volume (30 Days)
- KZIA 745.7K
- OTRK 1.2M
- Earning Date
- KZIA 07-22-2025
- OTRK 08-07-2025
- Dividend Yield
- KZIA N/A
- OTRK N/A
- EPS Growth
- KZIA N/A
- OTRK N/A
- EPS
- KZIA N/A
- OTRK N/A
- Revenue
- KZIA $1,549,158.00
- OTRK $10,183,000.00
- Revenue This Year
- KZIA N/A
- OTRK $50.12
- Revenue Next Year
- KZIA N/A
- OTRK $55.26
- P/E Ratio
- KZIA N/A
- OTRK N/A
- Revenue Growth
- KZIA 248983.08
- OTRK N/A
- 52 Week Low
- KZIA $2.86
- OTRK $0.41
- 52 Week High
- KZIA $79.00
- OTRK $5.53
- Technical
- Relative Strength Index (RSI)
- KZIA 72.75
- OTRK 14.77
- Support Level
- KZIA $5.86
- OTRK $0.42
- Resistance Level
- KZIA $7.20
- OTRK $0.52
- Average True Range (ATR)
- KZIA 1.17
- OTRK 0.08
- MACD
- KZIA 0.15
- OTRK -0.04
- Stochastic Oscillator
- KZIA 82.21
- OTRK 2.86
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The group provides a value-based behavioral healthcare company that identifies and engages people with unmet health needs using the proprietary Advanced Engagement System to improve clinical outcomes and reduce total cost of care. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.